Intraperitoneal alpha-2b interferon for advanced stage cancer of the ovary in complete remission or minimal residual disease;TRAITEMENT INTRAPERITONEAL PAR L'ALPHA 2B INTERFERON DANS LE CANCER DE L'OVAIRE AVANCE EN REMISSION COMPLETE OU AVEC MALADIE RESIDUELLE MINIME

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 25, Issue 1, 1996, Pages 101-102

  Cherchi, P L ^a   Dessole, S ^a   Esposito, F ^a   Ambrosini, G ^a   El Quandil, F Z ^a   Ambrosini, A ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT;

ADULT; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; LETTER; OVARY CANCER; AGED; CANCER STAGING; FOLLOW UP; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; OVARIECTOMY; OVARY TUMOR; PATHOLOGY; REMISSION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAPERITONEAL; INTERFERON ALFA-2B; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; OVARIECTOMY; REMISSION INDUCTION;

EID: 0029881080     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)